ClinicalTrials.govpublic full text
Sorafenib and TACE as Adjuvant Therapy for MVI in HCC Patients After Radical Resection
hepatocellular carcinoma, sorafenib, transcatheter arterial chemoembolization, microvascular invasion, interventional, na
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 899310
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.